General News 4: China’s Sinopharm vaccine is 79% effective, developer says, citing Phase 3 trial results

[bob_turner]

The vaccine, developed by the China National Pharmaceutical Group (Sinopharm), has shown a nearly 80 percent efficacy rate against the coronavirus, the company said. The vaccine was earlier approved for use in Bahrain and the UAE. The preliminary analysis on the Phase III trial has shown that the vaccine is safe to use and 79.34 percent effective against Covid-19, Chinese media reported, citing the developer’s subsidiary, the Beijing Institute of Biological Products....

Read more